{"id":"NCT02201901","sponsor":"Gilead Sciences","briefTitle":"Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis","officialTitle":"A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects With Chronic HCV Infection and Child-Pugh Class B Cirrhosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07","primaryCompletion":"2015-08","completion":"2015-11","firstPosted":"2014-07-28","resultsPosted":"2016-12-14","lastUpdate":"2018-11-15"},"enrollment":268,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus Infection"],"interventions":[{"type":"DRUG","name":"SOF/VEL","otherNames":["GS-7977/GS-5816","EpclusaÂ®"]},{"type":"DRUG","name":"RBV","otherNames":[]}],"arms":[{"label":"SOF/VEL 12 weeks","type":"EXPERIMENTAL"},{"label":"SOF/VEL+RBV 12 weeks","type":"EXPERIMENTAL"},{"label":"SOF/VEL 24 weeks","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of sofosbuvir (SOF)/velpatasvir (VEL) fixed dose combination (FDC) with and without ribavirin (RBV) for 12 weeks and SOF/VEL FDC for 24 weeks in adults with chronic hepatitis C virus (HCV) infection and Child-Pugh-Turcotte (CPT) class B cirrhosis.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"SOF/VEL 12 Weeks (Group 1)","deltaMin":83.3,"sd":null},{"arm":"SOF/VEL+RBV 12 Weeks (Group 2)","deltaMin":94.3,"sd":null},{"arm":"SOF/VEL 24 Weeks (Group 3)","deltaMin":87.8,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.001"},{"comp":"OG001","p":"<0.001"},{"comp":"OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":50,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["26569658","28404069","27847279"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":90},"commonTop":["Fatigue","Nausea","Headache","Anaemia","Diarrhoea"]}}